Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
UK leader promises a ‘bold offer’ on Brexit deal
Astros OF Springer (back) day-to-day
Sinclair sports deal proving a tough sell to...
Donald Trump Jr. reaches deal for Senate testimony
Alec Baldwin brings back Trump impression for...
Back off, haters — the last season of ‘Game of...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version